Parameters of bacterial killing and regrowth kinetics and antimicrobial effect examined in terms of area under the concentration-time curve relationships: Action of ciprofloxacin against Escherichia coli in an in vitro dynamic model

被引:87
作者
Firsov, AA [1 ]
Vostrov, SN [1 ]
Shevchenko, AA [1 ]
Cornaglia, G [1 ]
机构
[1] UNIV VERONA,INST MICROBIOL,I-37100 VERONA,ITALY
关键词
D O I
10.1128/AAC.41.6.1281
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Although many parameters have been described to quantitate the killing and regrowth of bacteria, substantial shortcomings are inherent in most of them, such as low sensitivity to pharmacokinetic determinants of the antimicrobial effect, an inability to predict a total effect, insufficient robustness, and uncertain interrelations between the parameters that prevent an ultimate determination of the effect. To examine different parameters, the kinetics of killing and regrowth of Escherichia coli (MIC, 0.013 mu g/ml) were studied in vitro by simulating a series of ciprofloxacin monoexponential pharmacokinetic profiles. Initial ciprofloxacin concentrations varied from 0.02 to 19.2 mu g/ml, whereas the half-life of 4 h was the same in all experiments. The following parameters were calculated and estimated: the time to reduce the initial inoculum (N-0) 10-, 100-, and 1,000-fold (T-90%, T-99%, and T-99.9%, respectively), the rate constant of bacterial elimination (k(elb)), the nadir level (N-min) in the viable count (N)-versus-time (t) curve, the time to reach N-min (t(min)), the numbers of bacteria that survived (N-tau) by the end of the observation period (tau), the area under the bacterial killing and regrowth curve (log N-A-t curve) from the zero point (time zero) to tau (AUBC), the area above this curve (AAC), the area between the control growth curve (log N-C-t curve) and the bacterial killing and regrowth curve (log N-A-t curve) from the zero point to tau (ABBC) or to the time point when log N-A reaches the maximal values observed in the log N-C-t curve (I-E; intensity of the effect), and the time shift between the control growth and regrowth curves (T-E; duration of the effect). Being highly sensitive to the AUC, I-E and T-E showed the most regular AUC relationships: the effect expressed by I-E or T-E increased systematically when the AUG or initial concentration of ciprofloxacin rose. Other parameters, especially T-90%, T-99%, T-99.9%, t(min), and log N-0 - log N-min = Delta log N-min, related to the AUC less regularly and were poorly sensitive to the AUC. T-E proved to be the best predictor and t(min) proved to be the worst predictor of the total antimicrobial effect reflected by I-E. Distinct feedback relationships between the effect determination and the experimental design were demonstrated. It was shown that unjustified shortening of the observation period, i.e., cutting off the log N-A-t curves, may lead to the degeneration of the AUG-response relationships, as expressed by log N-0 - log N-tau = Delta log N-tau, AUBC, AAC, or ABBC, to a point where it gives rise to the false idea of an AUC- or concentration-independent effect. Thus, use of I-E and T-E provides the most unbiased, robust, and comprehensive means of determining the antimicrobial effect.
引用
收藏
页码:1281 / 1287
页数:7
相关论文
共 39 条
  • [1] QUESTIONING DOSING REGIMENS OF CIPROFLOXACIN
    BAUERNFEIND, A
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 31 (05) : 789 - 798
  • [2] BERGAN T, 1986, PREDICTION ASSESSMEN, P27
  • [3] Blaser J, 1987, Prog Drug Res, V31, P349
  • [4] BIPHASIC KINETICS OF BACTERIAL KILLING BY QUINOLONES
    CARRET, G
    FLANDROIS, JP
    LOBRY, JR
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 (03) : 319 - 327
  • [5] ANTIMICROBIAL EFFECTS OF LOMEFLOXACIN INVITRO
    CHAMBERS, ST
    PEDDIE, BA
    ROBSON, RA
    BEGG, EJ
    BOSWELL, DR
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 (04) : 481 - 489
  • [6] EFFICACIES OF DIFFERENT VANCOMYCIN DOSING REGIMENS AGAINST STAPHYLOCOCCUS-AUREUS DETERMINED WITH A DYNAMIC IN-VITRO MODEL
    DUFFULL, SB
    BEGG, EJ
    CHAMBERS, ST
    BARCLAY, ML
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (10) : 2480 - 2482
  • [7] Firsov A A, 1991, Eur J Drug Metab Pharmacokinet, VSpec No 3, P406
  • [8] FIRSOV AA, 1989, ANTIBIOT KHIMIOTERAP, V34, P375
  • [9] Quantitative analysis of antimicrobial effect kinetics in an in vitro dynamic model
    FIRSOV, AA
    CHERNYKH, VM
    NAVASHIN, SM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (07) : 1312 - 1317
  • [10] Predictors of effect of ampicillin-sulbactam against TEM-1 beta-lactamase-producing Escherichia coli in an in vitro dynamic model: Enzyme activity versus MIC
    Firsov, AA
    Savarino, D
    Ruble, M
    Gilbert, D
    Manzano, B
    Medeiros, AA
    Zinner, SH
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (03) : 734 - 738